“I am humbled and honored to serve as RSNA president for the coming year,” Dr. Haffty will focus on expanding RSNA’s profile in the broader medical community, collaborating with other major medical societies and governmental agencies in promoting the value of the radiological sciences to patients and partners in health care delivery. Haffty was promoted to professor of therapeutic radiology in 2000, served as residency program director from 1992 through 2004, and as vice chairman and clinical director from 2002 to 2005.Īs president, Dr. He served on the faculty at Yale from 1988 through 2005. Haffty completed his medical school and residency training at Yale University School of Medicine in 1988 and spent the next 18 years specializing in breast, head and neck cancers in Yale’s Department of Therapeutic Radiology. He also serves as professor and chairman in the Department of Radiation Oncology at Rutgers Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School.ĭr. Haffty is associate vice chancellor, Cancer Programs, at Rutgers Biomedical and Health Sciences. Haffty, MD, is president of the Radiological Society of North America (RSNA) Board of Directors.ĭr. Wu hasn’t determined a specific path after medical school but knows she'd like cancer care to be part of her residency and future career.Bruce G. “When she was a second-year medical student she won a national oncology award from the American Radium Society ahead of medical oncology, surgical oncology and radiation oncology residents,” said McClelland. “Oncology is a really personal specialty, but the patients are so open and thankful-even to medical students.” “It’s very meaningful when you talk to patients and hear what they are feeling, as opposed to reading from a textbook,” said Wu. The Columbus, Ohio native is enjoying her third year of medical school and the rewarding personal connections she’s formed with patients. “It’s the flagship radiation oncology meeting in the U.S.” “She will also present breast cancer financial toxicity work at the American Society for Radiation Oncology annual meeting in October, “ said Wu’s mentor, Case Comprehensive Cancer Center member and Assistant Professor Shearwood McClelland III, MD. Wu will present her lymphoma care abstract at the ASCO symposium in October, but she is also studying financial toxicity and other cancers. It's the accumulation of these high costs that can create harmful effects on a patient's quality of life.” “Cancer treatments have a cost-but there is so much more involved-lost wages due to time off work, caregiving costs, transportation to treatments and much more. “It’s thinking about cancer costs from a broad perspective,” said Wu. She explains financial toxicity in simple terms. “We looked at what the patients would pay out-of-pocket instead of traditional cost-effective analyses that look at the hospital payer perspective,” said Wu. Wu’s project examines a hot topic in treating early-stage Hodgkin lymphoma- the cost-effectiveness and impact on patients if radiation therapy is omitted. It’s research she will soon present at the American Society of Clinical Oncology (ASCO) Quality Care Symposium. She earned her undergraduate degree from University of Pennsylvania in the subject, and is using that expertise to study financial toxicity and how it affects lymphoma patients. Third-year Case Western Reserve University medical student Victoria Wu knows a thing or two about economics. Researchers, Postdoctoral Fellows & Scholars Information.SOM Research Administration Class Payment Form.Commencement 2023: Graduating Student Spotlights.Clinical and Translational Science Collaborative.Entrepreneurship at the School of Medicine. SOM Office of Research Administration Staff Directory.Diversity, Equity, and Inclusive Excellence.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |